Copertina

Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Xiao‐Hui Zheng, Xi‐Zhao Li, Cao‐Li Tang, Yu‐Meng Zhang, Ting Zhou, Xiao‐Jing Yang, Ying Liao, Yong‐Qiao He, Tong‐Min Wang, Wen‐Qiong Xue, Wei‐Hua Jia
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	MedComm
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Structure‐based design of antibodies targeting the EBNA1 DNA‐binding domain to block Epstein–Barr virus latent infection and tumor growth
di: Yongyue Han, et al.
Pubblicazione: (2024)

SMARCAL1: a new target for taming tumor immune evasion
di: Ting Xiao, et al.
Pubblicazione: (2024)

An inflammatory liquid fingerprint predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
di: Modan Yang, et al.
Pubblicazione: (2024)

Optimization and validation of a virus‐like particle pseudotyped virus neutralization assay for SARS‐CoV‐2
di: Shuo Liu, et al.
Pubblicazione: (2024)

Development of a SARS‐CoV‐2 neutralization assay based on a pseudotyped virus using a HIV system
di: Ziteng Liang, et al.
Pubblicazione: (2024)

Critical roles and clinical perspectives of RNA methylation in cancer
di: Ganglei Li, et al.
Pubblicazione: (2024)

Dual Targeting of DNA and EGFR by ZYH005 Induces DNA Damage and Mitotic Catastrophe in Glioblastoma
di: Jianzheng Huang, et al.
Pubblicazione: (2026)

The Epstein–Barr Virus Envelope Glycoprotein BALF4 Promotes the Ubiquitination and Degradation of RNA Acetyltransferase NAT10 Suppressing Gastric Cancer Progression
di: Tianle Qiu, et al.
Pubblicazione: (2025)

Oligodendrocyte: Development, Plasticity, Biological Functions, Diseases, and Therapeutic Targets
di: Qiong Xiang, et al.
Pubblicazione: (2026)

Connection between oral health and chronic diseases
di: Di Fu, et al.
Pubblicazione: (2025)

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
di: Xiaoting Luo, et al.
Pubblicazione: (2024)

Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue
di: Qianqian Li, et al.
Pubblicazione: (2024)

Targeting esophageal carcinoma: molecular mechanisms and clinical studies
di: Wenjing Wang, et al.
Pubblicazione: (2024)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
di: Shiqi Li, et al.
Pubblicazione: (2024)

N6‐methyladenosine reader YTHDF3‐mediated zinc finger protein 41 inhibits hepatocellular carcinoma progression by transcriptional repression of Snail
di: Xinxin Li, et al.
Pubblicazione: (2024)

Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
di: Fei Wang, et al.
Pubblicazione: (2024)

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
di: Zheng Liu, et al.
Pubblicazione: (2025)

Chronic hepatitis B virus infection deteriorates disease outcome of coronavirus disease 2019 in hamster
di: Lunzhi Yuan, et al.
Pubblicazione: (2024)

A novel allosteric driver mutation of β‐glucuronidase promotes head and neck squamous cell carcinoma progression through STT3B‐mediated PD‐L1 N‐glycosylation
di: Zhonglong Liu, et al.
Pubblicazione: (2025)

Sepsis: the evolution of molecular pathogenesis concepts and clinical management
di: Zhongxue Feng, et al.
Pubblicazione: (2025)

Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
di: Junshu Li, et al.
Pubblicazione: (2024)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
di: TingDan Hu, et al.
Pubblicazione: (2024)

Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid Malignancies
di: Liping Liu, et al.
Pubblicazione: (2025)

Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
di: Wenhao Xu, et al.
Pubblicazione: (2024)

Single‐cell transcriptomics reveals IRF7 regulation of the tumor microenvironment in isocitrate dehydrogenase wild‐type glioma
di: Jinwei Li, et al.
Pubblicazione: (2024)

Targeting intracellular cancer proteins with tumor‐microenvironment‐responsive bispecific nanobody‐PROTACs for enhanced therapeutic efficacy
di: Changping Deng, et al.
Pubblicazione: (2025)

Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
di: Ming Zhou, et al.
Pubblicazione: (2025)

A Single‐Nucleus Transcriptomic Atlas Reveals Cellular and Genetic Characteristics of Alzheimer's‐Like Pathology in Aging Tree Shrews
di: Liu‐Lin Xiong, et al.
Pubblicazione: (2025)

Mechanism of Musashi2 affecting radiosensitivity of lung cancer by modulating DNA damage repair
di: Hongjin Qu, et al.
Pubblicazione: (2024)

Single‐cell transcriptomics reveal the remodeling landscape of bladder in patients with obstruction‐induced detrusor underactivity
di: Jiawei Chen, et al.
Pubblicazione: (2024)

CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinoma
di: Zitong Zhao, et al.
Pubblicazione: (2024)

Inducing disulfidptosis in tumors:potential pathways and significance
di: Tao Mi, et al.
Pubblicazione: (2024)

IgA Antibodies Reveal Covert Infection With Mpox Virus in People Living With HIV in the Community: A Prospective Longitudinal Cohort Survey
di: Rui Song, et al.
Pubblicazione: (2026)

Unlocking fresh perspectives: molecular breakthroughs in pediatric acute myeloid leukemia classification and prognosis
di: Yu Tao, et al.
Pubblicazione: (2024)

Histone Modifications in Cardiovascular Disease: Mechanisms and Therapeutic Opportunities
di: Yu Zheng, et al.
Pubblicazione: (2026)

Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
di: Ying Lu, et al.
Pubblicazione: (2025)

Dynamic Immune Reconstitution and Clinical Outcomes of Three Different Protocols for Haploidentical Hematopoietic Stem Cell Transplantation
di: Xiao‐Di Ma, et al.
Pubblicazione: (2026)

The Systematic Comparison of Enhancer of Zeste Homolog‐2‐, Bromodomain‐containing Proteins‐, Histone Deacetylase‐, and DNA‐methyltransferase 1‐inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti‐tumoral and Immunomodulatory Activities
di: Valentina Rigo, et al.
Pubblicazione: (2025)

Multiorgan proteomic analysis of infected animal models predict potential host factors for chikungunya virus
di: Dongdong Lin, et al.
Pubblicazione: (2025)

The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
di: Yalun Li, et al.
Pubblicazione: (2024)